Showing results (981-990 of 1,482) with videos related to

Sort By:
Pageof 149
Journal of the American Chemical Society|February 5, 2014
Experimental and computational study of BODIPY dye-labeled cavitand dynamicsIgor Pochorovski, Tim Knehans, Daniel Nettels, et al.
Emerging Infectious Diseases|March 19, 2020
Ebola Virus Neutralizing Antibodies in Dogs from Sierra Leone, 2017Kerstin Fischer, Roland Suluku, Sarah Katharina Fehling, et al.
NPJ Genomic Medicine|January 17, 2025
Adaptive evolution of SARS-CoV-2 during a persistent infection for 521 days in an immunocompromised patientHanno Schmidt, Lea Schick, Jürgen Podlech, et al.
Transboundary and Emerging Diseases|October 19, 2019
Serological evidence of exposure to ebolaviruses in domestic pigs from GuineaKerstin Fischer, Alimou Camara, Cécile Troupin, et al.
Stroke|November 2, 2013
Meta-analysis of the efficacy of different training strategies in animal models of ischemic strokeAntje Schmidt, Jürgen Wellmann, Matthias Schilling, et al.
Biomolecules|December 24, 2021
Which Properties Allow Ligands to Open and Bind to the Transient Binding Pocket of Human Aldose Reductase?Anna Sandner, Khang Ngo, Christoph P Sager, et al.
Nucleic Acids Research|August 21, 2019
PPARβ/δ recruits NCOR and regulates transcription reinitiation of ANGPTL4Nathalie Legrand, Clemens L Bretscher, Svenja Zielke, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|August 14, 2019
Targeting a Large Active Site: Structure-Based Design of Nanomolar Inhibitors of Trypanosoma brucei Trypanothione ReductaseRaoul De Gasparo, Ondrej Halgas, Dora Harangozo, et al.
Journal of Medicinal Chemistry|February 29, 2012
(Z)-2-(2-bromophenyl)-3-{[4-(1-methyl-piperazine)amino]phenyl}acrylonitrile (DG172): an orally bioavailable PPARβ/δ-selective ligand with inverse agonistic propertiesSonja Lieber, Frithjof Scheer, Wolfgang Meissner, et al.
Stroke|October 25, 2011
Successful regeneration after experimental stroke by granulocyte-colony stimulating factor is not further enhanced by constraint-induced movement therapy either in concurrent or in sequential combination therapyKai Diederich, Verena Quennet, Henrike Bauer, et al.
Pageof 149